JPH027942B2 - - Google Patents

Info

Publication number
JPH027942B2
JPH027942B2 JP16145281A JP16145281A JPH027942B2 JP H027942 B2 JPH027942 B2 JP H027942B2 JP 16145281 A JP16145281 A JP 16145281A JP 16145281 A JP16145281 A JP 16145281A JP H027942 B2 JPH027942 B2 JP H027942B2
Authority
JP
Japan
Prior art keywords
formula
chloroform
general formula
under reduced
reduced pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP16145281A
Other languages
Japanese (ja)
Other versions
JPS5862147A (en
Inventor
Soji Kanao
Kyoshi Tamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP16145281A priority Critical patent/JPS5862147A/en
Publication of JPS5862147A publication Critical patent/JPS5862147A/en
Publication of JPH027942B2 publication Critical patent/JPH027942B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は新規硝酸エステル誘導体に関するもの
である。 本発明の化合物は一般式() 〔式中R1は水素原子又はニトロ基を、R2は炭
素数1〜6のω―(ニトロオキシ)アルキル基も
しくは炭素数2〜7のω―(カルボキシ)アルキ
ル基または一般式() (式中R1は前記に同じ。)で表わされる基を示
す。〕で表わされ、血管拡張作用を呈することか
ら循環器系治療剤のなかでも虚血性心疾患治療薬
として有用である。 本発明の化合物は、次の一般式() (式中R3はω―ハイドロキシアルキル基また
はω―カルボキシアルキル基のアルカリ金属塩も
しくはアルカリ土類金属塩を示す。)で表わされ
るアルコール誘導体を発煙硝酸中、低温で反応さ
せて製造することが出来る。一方、一般式()
のR2が一般式()で示される基である硝酸エ
ステルは上記の製造法で得られた一般式() (式中R1は前記に同じ。)で表わされる化合物
を、テトラヒドロフラン、クロロホルム、ジクロ
ロメタン等の溶媒中、トリエチルアミン存在下、
クロル炭酸アルキルと反応せしめ、混合酸無水物
とし、続いてシスタミンと反応させることにより
製造することが出来る。 かくして製された本発明化合物の代表的化合物
であるパンテノール三硝酸エステルの冠血管拡張
作用について、ライフサイエンス23巻1609頁、
1978年(今井昭一等)に記載の方法に準じ、モル
モツト摘出心臓標本にてランゲンドルフ氏法によ
り30μg投与時の冠血管潅流量を検討した結果、
上記本発明化合物がニトログリセリン投与時の冠
血管血流量増加作用の約70%の活性を呈すること
を確認した。 以下、本発明を実施例により説明する。 実施例 1 D―パンテノール3.0gを氷酢酸4mlに溶かした
溶液を、氷水浴中、0〜2℃に冷却した発煙硝酸
(比重1.52)25ml中に滴下する。滴加した後、更
に3.5時間、0〜5℃にて撹拌した後、氷水100ml
中に注加する。得られた水溶液をクロロホルムに
て抽出する。抽出液を水洗し、無水硫酸ナトリウ
ムで乾燥後、減圧下に濃縮する。得られた油状物
の残渣をシリカゲル50gを用いてカラムクロマト
を行ない、クロロホルムにて溶出し、シリカゲル
薄層クロマト〔展開溶媒:クロロホルム―イソプ
ロピルエーテル(1:1)の混合物〕にてRf値
約0.7のスポツトを認めるフラクシヨンを集め、
減圧下に濃縮すれば無色プリズム晶のパンテノー
ル三硝酸エステル2.43gを得る。 融点 54.5〜56℃ NMR(CDCl3,90MHz)δppm: 1.19,1.21(各々3H,s,―CH3 ) 2.01(2H,m,―CH2CH2 CH2―) 3.46(2H,q,―NHCH2 CH2―) 4.45(2H,s,
The present invention relates to novel nitrate ester derivatives. The compound of the present invention has the general formula () [In the formula, R 1 is a hydrogen atom or a nitro group, R 2 is an ω-(nitrooxy)alkyl group having 1 to 6 carbon atoms, an ω-(carboxy)alkyl group having 2 to 7 carbon atoms, or a general formula () (In the formula, R 1 is the same as above.) ] and exhibits a vasodilatory effect, making it useful as a therapeutic agent for ischemic heart disease among cardiovascular system therapeutic agents. The compound of the present invention has the following general formula () (In the formula, R 3 represents an alkali metal salt or an alkaline earth metal salt of an ω-hydroxyalkyl group or an ω-carboxyalkyl group.) It can be produced by reacting an alcohol derivative represented by the following in fuming nitric acid at a low temperature. I can do it. On the other hand, the general formula ()
The nitric acid ester in which R 2 is a group represented by the general formula () has the general formula () obtained by the above production method. (In the formula, R 1 is the same as above.) In a solvent such as tetrahydrofuran, chloroform, dichloromethane, etc., in the presence of triethylamine,
It can be produced by reacting with an alkyl chlorocarbonate to form a mixed acid anhydride, and then reacting with cystamine. Regarding the coronary vasodilator effect of panthenol trinitrate, which is a representative compound of the compound of the present invention thus prepared, Life Science Vol. 23, p. 1609,
According to the method described in 1978 (Shoichi Imai et al.), we investigated the coronary vascular perfusion rate when 30 μg was administered using Langendorff's method using isolated heart specimens from guinea pigs.
It was confirmed that the above-mentioned compound of the present invention exhibits approximately 70% of the activity of increasing coronary blood flow when nitroglycerin is administered. The present invention will be explained below using examples. Example 1 A solution of 3.0 g of D-panthenol dissolved in 4 ml of glacial acetic acid is added dropwise to 25 ml of fuming nitric acid (specific gravity 1.52) cooled to 0-2°C in an ice-water bath. After the dropwise addition, the mixture was further stirred for 3.5 hours at 0 to 5°C, and then added with 100 ml of ice water.
Pour inside. The resulting aqueous solution is extracted with chloroform. The extract is washed with water, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The resulting oily residue was subjected to column chromatography using 50 g of silica gel, eluted with chloroform, and silica gel thin layer chromatography [developing solvent: chloroform-isopropyl ether (1:1) mixture] to obtain an Rf value of approximately 0.7. Collect the flux that recognizes the spot,
Concentration under reduced pressure yields 2.43 g of colorless prismatic panthenol trinitrate. Melting point 54.5-56℃ NMR (CDCl 3 , 90MHz) δppm: 1.19, 1.21 (3H, s, -CH 3 respectively) 2.01 (2H, m, -CH 2 CH 2 CH 2 -) 3.46 (2H, q, ―NHC H 2 CH 2 ―) 4.45 (2H, s,

【式】) 4.53(2H,t,―CH2CH2 ONO2) 5.13(1H,s,[Formula]) 4.53 (2H, t, - CH 2 C H 2 ONO 2 ) 5.13 (1H, s,

【式】) 6.56(1H,br,―CON―) 元素分析(%) C9H16N4O10として 計算値 C31.77,H 4.74,N 16.47 実測値 C31.56,H 4.33,N 16.44 上記シリカゲルカラムクロマトをさらにクロロ
ホルム―アセトン(1:1)の混合溶媒で溶出
し、シリカゲル薄層クロマトにてRf値約0.4を示
すフラクシヨンを合わせ、減圧下に濃縮して無色
油状物としてN―(4―ニトロオキシ―3,3―
ジメチル―2―ハイドロキシブチル)―3―アミ
ノプロピルナイトレート0.8gを得る。 NMR(CDCl3,90MHz)δppm: 1.05,1.07(各々3H,s,―CH3 ) 2.00(2H,m,―CH2CH2 CH2―) 3.43(2H,q,―NHCH2 CH2―) 4.01(1H,s,
[Formula]) 6.56 (1H, br, -CON H -) Elemental analysis (%) As C 9 H 16 N 4 O 10 Calculated value C31.77, H 4.74, N 16.47 Actual value C31.56, H 4.33, N 16.44 The above silica gel column chromatography was further eluted with a mixed solvent of chloroform-acetone (1:1), and the fractions showing an Rf value of about 0.4 in the silica gel thin layer chromatography were combined and concentrated under reduced pressure to form a colorless oily N- (4-nitrooxy-3,3-
0.8 g of dimethyl-2-hydroxybutyl)-3-aminopropyl nitrate is obtained. NMR (CDCl 3 , 90MHz) δppm: 1.05, 1.07 (3H, s, -CH 3 respectively) 2.00 (2H, m, -CH 2 CH 2 CH 2 -) 3.43 (2H, q, -NHC H 2 CH 2 ―) 4.01 (1H, s,

【式】) 4.45(2H,s,【formula】) 4.45(2H,s,

【式】) 4.55(2H,t,―CH2CH2 ONO2) 7.13(1H,br,―CON―) 実施例 2 D―パントテン酸ナトリウム3.0gを1〜3℃に
冷却した発煙硝酸(比重1.52)21ml中に少量づつ
加える。加え終つた後、更に2〜5℃にて3時間
撹拌する。その後、反応液を氷水150ml中に注加
し、酢酸エチルにて抽出する。酢酸エチル層を水
洗し、無水硫酸ナトリウムで乾燥後、減圧下に濃
縮する。残留する油状物をシリカゲル35gを用い
てカラムクロマトを行なう。クロロホルム500ml
を流した後、クロロホルム―メタノール(20:
1)の混合溶媒にて溶出し、得られたフラクシヨ
ンを減圧下に濃縮して無色油状物のパントテン酸
二硝酸エステル3.5gを得る。 NMR(CDCl3,90MHz)δppm: 1.16,1.18(各々3H,s,―CH3 ) 2.64(2H,t,―CH2CH2 COOH) 3.60(2H,q,―NHCH2 CH2―) 4.41(2H,s,
[Formula]) 4.55 (2H, t, - CH 2 C H 2 ONO 2 ) 7.13 (1H, br, - CON H -) Example 2 Fuming nitric acid in which 3.0 g of sodium D-pantothenate was cooled to 1 to 3°C (Specific gravity 1.52) Add little by little to 21ml. After the addition is complete, the mixture is further stirred at 2 to 5°C for 3 hours. Thereafter, the reaction solution was poured into 150 ml of ice water and extracted with ethyl acetate. The ethyl acetate layer is washed with water, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The remaining oil is subjected to column chromatography using 35 g of silica gel. Chloroform 500ml
After flushing, chloroform-methanol (20:
Elute with the mixed solvent of 1) and concentrate the obtained fraction under reduced pressure to obtain 3.5 g of pantothenic acid dinitrate as a colorless oil. NMR (CDCl 3 , 90MHz) δppm: 1.16, 1.18 (3H, s, -CH 3 respectively) 2.64 (2H, t, -CH 2 CH 2 COOH) 3.60 (2H, q, -NHC H 2 CH 2 - ) 4.41(2H,s,

【式】) 5.10(1H,s,【formula】) 5.10 (1H, s,

【式】) 7.00(1H,br,―CON―) 10.1(1H,br,―COO) 実施例 3 実施例2で得られたパントテン酸二硝酸エステ
ル2.5gをトリエチルアミン1.1gとテトラヒドロフ
ラン20mlの混液中に溶かし、氷水浴中で冷却す
る。これにクロル炭酸エチル0.88gとテトラヒド
ロフラン8mlの混液を滴加した後、3〜5℃にて
1.5時間撹拌する。この溶液にシスタミン・二塩
酸塩0.91g、トリメチルアミン1.8g、テトラヒド
ロフラン20mlの混合液を滴加した後、3〜5℃に
て2時間撹拌する。反応溶液を減圧下に濃縮し、
残渣にクロロホルム100mlを加え撹拌する。この
溶液を2N―水酸化ナトリウム水溶液、希塩酸、
水にて順次洗浄した後、無水硫酸ナトリウムで乾
燥し、減圧下に濃縮して得られる油状物をシリカ
ゲル40gを用いてカラムクロマトを行なう。クロ
ロホルム―メタノール(20:1)の混合溶媒にて
溶出し、目的物を含有するフラクシヨンを合わせ
減圧濃縮して得られる残渣をクロロホルム―エー
テル混液より再結晶して無色粉末のパンテチン四
硝酸エステル1.02gを得る。 融点 104〜108℃ NMR(CDCl3,90MHz)δppm: 1.18(12H,s,―CH3 ×4) 2.50(4H,m,―CH2CH2 CONH―×2) 2.83(4H,m,―CH2 ―S―S―CH2 ―) 3.60(8H,m,―CONH―CH2 CH2−×4) 4.41(4H,s,
[Formula]) 7.00 (1H, br, -CON H -) 10.1 (1H, br, -COO H ) Example 3 2.5 g of pantothenic acid dinitrate obtained in Example 2 was mixed with 1.1 g of triethylamine and 20 ml of tetrahydrofuran. Dissolve in mixture and cool in an ice-water bath. A mixture of 0.88 g of ethyl chlorocarbonate and 8 ml of tetrahydrofuran was added dropwise to this, and the mixture was heated at 3 to 5°C.
Stir for 1.5 hours. A mixed solution of 0.91 g of cystamine dihydrochloride, 1.8 g of trimethylamine, and 20 ml of tetrahydrofuran was added dropwise to this solution, followed by stirring at 3 to 5°C for 2 hours. The reaction solution was concentrated under reduced pressure,
Add 100 ml of chloroform to the residue and stir. This solution was mixed with 2N sodium hydroxide aqueous solution, dilute hydrochloric acid,
After sequentially washing with water, drying over anhydrous sodium sulfate and concentrating under reduced pressure, the resulting oily substance was subjected to column chromatography using 40 g of silica gel. Elute with a mixed solvent of chloroform-methanol (20:1), combine the fractions containing the target product, concentrate under reduced pressure, and recrystallize the resulting residue from a chloroform-ether mixture to obtain 1.02 g of pantethine tetranitrate as a colorless powder. get. Melting point 104-108℃ NMR (CDCl 3 , 90MHz) δppm: 1.18 (12H, s, -CH 3 × 4) 2.50 (4H, m, -CH 2 CH 2 CONH - × 2) 2.83 (4H, m, -C H 2 -S-S-C H 2 -) 3.60 (8H, m, -CONH-C H 2 CH 2 -×4) 4.41 (4H, s,

【式】) 5.07(2H,s,【formula】) 5.07(2H,s,

【式】) 6.90,7.60(各々2H,br,―CON−×2) 元素分析値(%) C22H38N8O16S2として 計算値 C 35.96,H 5.21,N 15.25 実測値 C 35.93,H 5.26,N 14.96[Formula]) 6.90, 7.60 (2H, br, - CON H - x 2 respectively) Elemental analysis value (%) Calculated value as C 22 H 38 N 8 O 16 S 2 C 35.96, H 5.21, N 15.25 Actual value C 35.93, H 5.26, N 14.96

Claims (1)

【特許請求の範囲】 1 一般式 [式中R1は水素原子又はニトロ基を、R2は炭
素数1〜6のω―(ニトロオキシ)アルキル基若
しくは炭素数2〜7のω―(カルボキシ)アルキ
ル基又は一般式 (式中R1は前記に同じ。)で表される基を示
す。]で表わされる硝酸エステル誘導体。
[Claims] 1. General formula [In the formula, R 1 is a hydrogen atom or a nitro group, R 2 is an ω-(nitrooxy)alkyl group having 1 to 6 carbon atoms, an ω-(carboxy)alkyl group having 2 to 7 carbon atoms, or a general formula (In the formula, R 1 is the same as above.) ] A nitrate ester derivative represented by.
JP16145281A 1981-10-09 1981-10-09 Nitric acid ester derivative Granted JPS5862147A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16145281A JPS5862147A (en) 1981-10-09 1981-10-09 Nitric acid ester derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16145281A JPS5862147A (en) 1981-10-09 1981-10-09 Nitric acid ester derivative

Publications (2)

Publication Number Publication Date
JPS5862147A JPS5862147A (en) 1983-04-13
JPH027942B2 true JPH027942B2 (en) 1990-02-21

Family

ID=15735366

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16145281A Granted JPS5862147A (en) 1981-10-09 1981-10-09 Nitric acid ester derivative

Country Status (1)

Country Link
JP (1) JPS5862147A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284872A (en) * 1989-09-12 1994-02-08 Schwarz Pharma Ag Nitrato alkanoic acid derivatives, methods for their production, pharmaceutical compositions containing the derivatives and medicinal uses thereof
IL120531A (en) * 1997-03-26 2006-12-31 Yissum Res Dev Co Nitric oxide donors and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JPS5862147A (en) 1983-04-13

Similar Documents

Publication Publication Date Title
JPH06135948A (en) Styrene derivative or its salt
US4863926A (en) Nitro aliphatic compounds, process for preparation thereof and use thereof
JPH027942B2 (en)
US5233041A (en) Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone from a 2,3-unsaturated-1-cyclopentanylpurinone
JPS61155346A (en) Alkoxymethyl ether and alkoxymethyl ester derivative
JPS60181056A (en) Preparation of n-(4-(3-aminopropylaminobutyl)-2,2- dihydroxyethanamide
TWI812679B (en) Process for preparing soluble guanylate cyclase stimulators
EP0713865B1 (en) 2-Aminobenzenesulphonic acid and 2-aminobenzenesulphonyl chloride derivatives, their preparation and their use as synthetic intermediates
JP2684749B2 (en) Bis- (4-fluoro-2-chlorophenyl) disulfide derivative
US4454336A (en) Derivatives of 3-(formylmethylthio)-propanoate
US4780542A (en) Process for the synthesis of esters and amides of carboxylic acids
JPH04217650A (en) Production of acid addition salt of delta-amino-levulinic acid
US4866197A (en) Production of N-((2-alkoxy-6-methoxy-5-(trifluoromethyl)-1-naphthalenyl)carbonyl)-N-methylglycine esters
US4376734A (en) Process for 3-amino-steroid preparation
JPS6139957B2 (en)
FR2693197A1 (en) New phenyl-quinolinyl-methyl-imidazo-pyridine derivs. - useful as angiotensin (II) antagonists for treating hypertension, glaucoma, etc.
JPH013194A (en) 2'-Bromo-2',3'-didehydro-2',3'-dideoxycytidine and its production method
US4914243A (en) Production of 2-alkoxy or aryl(lower)alkoxy-6-methoxy-1-naphthalenecarboxaldehyde
KR950006149B1 (en) Novel n-(2-haloalkanoyloxy)succinimide derivative and manufacturing method thereof
JP3481963B2 (en) Method for producing organic germanium compound
JPS59157097A (en) Alpha,alpha-trehalose fatty acid tetraester derivative and its preparation
JPS60166680A (en) Preparation of swainsonine
JPS6124568A (en) Preparation of dihydropyridine ester
JPH0119384B2 (en)
JPH0543603A (en) (galactopyranosyl)cyclomaltheptaose, preparation thereof, and intermediate therefor